-
2022-500782-27-00
7
2023-11-14
relapsed/refractory Multiple Myeloma
-
2023-503422-39-00
5
2023-10-20
Hepatocellular Carcinoma (HCC)
-
2022-501419-15-00
5
2023-08-23
Atrial Fibrillation
-
2024-510627-20-00
5
2023-07-28
Non-alcoholic Steatohepatitis (NASH) Cirrhosis
-
2022-501352-28-00
5
2023-06-07
Severe community-acquired pneumonia (sCAP)
-
2022-500687-35-00
9
2023-04-04
Refractory Mantle Cell Lymphoma
-
2024-513460-26-00
5
2023-03-29
Refractory Chronic Cough, Including Unexplained Chronic Cough
-
2024-511169-12-00
5
2023-03-28
Non-Small Cell Lung Cancer
-
2023-507187-39-00
5
2023-03-23
High-Risk Non-muscle-invasive Bladder Cancer
-
2024-512890-28-00
5
2023-03-20
Primary immune thrombocytopenia (ITP)
-
2023-504832-16-00
4
2023-01-24
DIFFUSE LARGE B CELL LYMPHOMA
-
2023-505992-54-00
3
2022-10-21
Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)
-
2023-509429-37-00
5
2022-10-03
Advanced or Metastatic Non-Small Cell Lung Cancer
-
2023-507964-38-00
5
2022-09-01
Metastatic or Locally Advanced Epidermal Growth Factor Receptor-mutate
-
2024-511021-58-00
3
2022-08-02
Extensive Stage Small cell lung cancer (ES-SCLC)
-
2023-505974-14-00
5
2022-06-23
Multiple Sclerosis (MS)
-
2023-503640-14-00
5
2022-02-17
Newly diagnosed Philadelphia-negative B-cell precursor Acute Lymphobla
-
2023-508242-18-00
6
2021-12-21
Crohn's disease
-
2023-508248-23-00
5
2021-11-26
Non-alcoholic steatohepatitis (NASH)
-
2024-510735-21-00
5
2021-11-26
Atherosclerotic cardiovascular disease (ASCVD)
-
2023-503441-55-00
4
2021-10-14
Relapsed/Refractory Multiple Myeloma
-
2023-508690-92-00
11
2021-09-20
IgA Nephropathy
-
2023-503772-24-00
10
2021-09-15
IgA Nephropathy
-
2024-514326-23-00
11
2021-09-10
Crohn's disease